» Articles » PMID: 35870141

Melanoma in Women of Childbearing Age and in Pregnancy in California, 1994-2015: a Population-based Cohort Study

Overview
Date 2022 Jul 23
PMID 35870141
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Melanoma is one of the most common malignancies during pregnancy. There is debate regarding the impact of pregnancy on the prognosis of melanoma. Recent large population-based studies from the United States are lacking.

Objectives: To determine the characteristics and survival of women with pregnancy-associated melanoma.

Methods: This population-based, retrospective cohort study used California Cancer Registry data linked with state-wide hospitalization and ambulatory surgery data to identify 15-44-year-old female patients diagnosed with melanoma in 1994-2015, including pregnant patients. Multivariable logistic regression compared demographic and clinical characteristics between pregnant and non-pregnant women with melanoma. Multivariable cox proportional hazards regression models assessed melanoma-specific and overall survival.

Results: We identified 13 108 patients, of which 1406 were pregnant. Pregnancy-associated melanoma was more frequent in Hispanic compared to non-Hispanic White women. Melanoma occurring post-partum was associated with greater tumour thickness (2.01-4.00 vs. 0.01-1.00 mm, odds ratio 1.75, 95% confidence interval: 1.03-2.98). There were otherwise no significant differences between pregnant and non-pregnant women. Worse survival was associated with Asian, Black and Native American race/ethnicity (vs. non-Hispanic White), lower neighbourhood socio-economic status, public insurance, tumour site, greater tumour thickness and lymph node involvement, but not pregnancy.

Conclusions: Melanoma occurring post-partum was associated with greater tumour thickness, but pregnancy status did not affect survival after melanoma. Race/ethnicity, socio-economic status and health insurance impacted survival, emphasizing the importance of reducing health disparities.

Citing Articles

["Red flags" during pregnancy-skin symptoms and their causes during pregnancy].

Bohne A, Langen K, Glaser R Dermatologie (Heidelb). 2024; 75(11):837-844.

PMID: 39384593 DOI: 10.1007/s00105-024-05419-3.


Melanoma in pregnancy.

Czeyda-Pommersheim F, Kluger H, Langdon J, Menias C, VanBuren W, Leventhal J Abdom Radiol (NY). 2023; 48(5):1740-1751.

PMID: 36719425 DOI: 10.1007/s00261-022-03796-8.

References
1.
Youl P, Baade P, Parekh S, English D, Elwood M, Aitken J . Association between melanoma thickness, clinical skin examination and socioeconomic status: results of a large population-based study. Int J Cancer. 2010; 128(9):2158-65. DOI: 10.1002/ijc.25540. View

2.
Lens M, Rosdahl I, Newton-Bishop J . Cutaneous melanoma during pregnancy: is the controversy over?. J Clin Oncol. 2009; 27(19):e11-2. DOI: 10.1200/JCO.2009.22.2588. View

3.
Haque W, Verma V, Butler E, Teh B . Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States. J Immunother. 2019; 42(6):228-235. DOI: 10.1097/CJI.0000000000000264. View

4.
Weber J, Mandala M, Del Vecchio M, Gogas H, Arance A, Cowey C . Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. N Engl J Med. 2017; 377(19):1824-1835. DOI: 10.1056/NEJMoa1709030. View

5.
Mackie R, Bufalino R, Morabito A, Sutherland C, Cascinelli N . Lack of effect of pregnancy on outcome of melanoma. For The World Health Organisation Melanoma Programme. Lancet. 1991; 337(8742):653-5. DOI: 10.1016/0140-6736(91)92462-b. View